Research library

Every indexed study on every peptide in the database, with a machine summary and the numbers that matter pulled out. Filter on the left; the register updates as you go.

2255studies indexed1010with human data129registered trials1946carry a numeric findingLibrarian added 23 studies today

Showing 3 studiesSortNewest indexed ▾

grade

Neoagarotetraose from Marine Red Algae Attenuates Hypertensive Vascular Remodeling by Targeting FoxO4 to Inhibit Mitochondrial Superoxide Generation.

FOXO4-DRI (FOXO4-D-Retro-Inverso) · Journal of agricultural and food chemistry · Observational · Preclinical

NA4 may reduce oxidative stress and lower blood pressure in hypertensive rats, but its effects in humans are not established.

NA4 lowered blood pressure in SHR after 4 weeks of oral administration at doses of 200 or 250 mg/kg/day.

summary

Full text read

Source →

grade

FOXO4 as a Redox-Sensitive Regulator of Antioxidant Defense and Cellular Senescence: Cysteine-Based Signaling, p53 Interaction, and Therapeutic Targeting.

FOXO4-DRI (FOXO4-D-Retro-Inverso) · Antioxidants (Basel, Switzerland) · 2023 · Review

FOXO4 is implicated in redox signaling and cellular senescence, but its clinical applications and direct antioxidant effects are not yet validated in humans.

Not reported in abstract.

summary

Full text read

Source →

grade

FOXO family and neurodegenerative diseases: Mechanisms of action and therapeutic potential.

FOXO4-DRI (FOXO4-D-Retro-Inverso) · europepmc · 2026 · Review

FOXO transcription factors play diverse roles in neurodegenerative diseases, but effective therapies targeting these pathways are still in early development stages.

summary

Full text read

Source →

Showing 3 of 3